Impact of Bevacizumab on Parenchymal Damage and Functional Recovery of the Liver in Patients With Colorectal Liver Metastases

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2095-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients With Colorectal Liver Metastases

Annals of Surgical Oncology
OncologySurgery
2016English

Chemotherapy With Bevacizumab Does Not Affect Liver Regeneration After Portal Vein Embolization in the Treatment of Colorectal Liver Metastases

Annals of Surgical Oncology
OncologySurgery
2008English

Colorectal Liver Metastases

Journal of Gastrointestinal Surgery
SurgeryGastroenterology
2012English

A Systematic Review of a Liver‐first Approach in Patients With Colorectal Cancer and Synchronous Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2014English

Second and Third Laparoscopic Liver Resection for Patients With Recurrent Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2016English

Surgical Treatment of Patients With Colorectal Cancer and Synchronous Liver Metastases

HPB
HepatologyGastroenterology
2016English

Impact of Postoperative Liver Failure on Surgical and Long-Term Outcomes After Resection of Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2016English

Perioperative Chemotherapy With Bevacizumab and Liver Resection for Colorectal Cancer Liver Metastasis

HPB
HepatologyGastroenterology
2010English

Genomic Characterization of Liver Metastases From Colorectal Cancer Patients

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy